Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

HLA CONTROL SERA

K-Number: K791118 · 1979-08-03

ApplicantCalbiochem-Behring Corp.
Decision Date1979-08-03
Product CodeLGO
Advisory CommitteeHE
DecisionSubstantially Equivalent

Device Summary

HLA CONTROL SERA is the device name listed in this FDA 510(k) record. The listed applicant is Calbiochem-Behring Corp.. It received FDA 510(k) clearance on 1979-08-03 under 510(k) number K791118. The device is classified under product code LGO. It was reviewed by the HE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the HLA CONTROL SERA?

HLA CONTROL SERA is a medical device that received FDA 510(k) clearance on 1979-08-03. The listed applicant is Calbiochem-Behring Corp.. The 510(k) number is K791118.

When did HLA CONTROL SERA receive FDA 510(k) clearance?

HLA CONTROL SERA received FDA 510(k) clearance on 1979-08-03, under 510(k) number K791118.

Who is the listed applicant for HLA CONTROL SERA?

The FDA 510(k) record lists Calbiochem-Behring Corp. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for HLA CONTROL SERA?

The FDA product code for HLA CONTROL SERA is LGO.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Calbiochem-Behring Corp. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K831811REVOLUTION RADIAL IMMUNODIFFUSION PLATEK831036ENA TEST KIT SM & RNP AUTO ANTIBODYK830214AFT SYSTEM IIIK820812CREATINE KINASE-MB KITK813493ENZYGNOST TM RUBELLA IGMK820088AFT SYSTEM PROFICIENCY TESTING PROGRAM

View all 41 devices →

Related Devices (Code: LGO)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K894947PLATELIA TOXO IGG KITKallestad Diag, A Div. of Erbamont, Inc.K874544SNAP(R) CAMPYLOBACTER CULTURE IDENT DIAGNOSTIC KITMolecular Biosystems, Inc.K761009LYMPHOCYTE TYPING, POSITIVE CONTROLHyland Therapeutic Div., Travenol LaboratoriesK761008LYMPHOCYTE TYPING, NEGATIVE CONTROLHyland Therapeutic Div., Travenol Laboratories

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑